A Novel Anticoagulation Method Based on Electrochemical Characteristics of Blood: An in vitro Study

Clinical Engineering - Methods Article

Jahanbani A.a· Goodarzi M.b· Sajjadi Dezfouli S.M.c· Yourdkhani M.R.d· Eskandari Roozbahani N.e

Author affiliations

aDVM, Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Shahid Chamran University, Ahvaz, Iran
bDepartment of Electrical Engineering, Faculty of Engineering, Islamic Azad University, Garmsar Branch, Garmsar, Iran
cDVM, Resident of Veterinary Surgery, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran
dAnalytical Chemistry Master, University of Mazandaran, Babolsar, Iran
eClinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Abstract of Clinical Engineering - Methods Article

Received: November 05, 2021
Accepted: July 15, 2022
Published online: September 20, 2022

Number of Print Pages: 10
Number of Figures: 4
Number of Tables: 2

ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)

For additional information: https://www.karger.com/BPU

Abstract

This in vitro experimental investigation aimed to provide a novel method for preventing blood clotting based on the electrochemical characteristics of blood. Using this method in cases such as dialysis can minimize the risk of blood clots and also avoid hemorrhagic risk for patients. Blood samples were collected from 13 sheep (45 kg) (25 mL), and the clotting time (CT) was measured using a 20-min cutoff after they were separated into control and experimental samples. The test blood sample was put in a cell designed with two aluminum electrodes (positive pole/anode) located in a container containing 0.9% sodium chloride (as a salt bridge) and a platinum (negative pole/cathode) linked to a power supply (−3.5 V, 1 mA/cm2). Biochemical and hematological tests to check blood damage and clotting were performed. The control sample coagulated after 8 min, while the electrified blood did not, even at the end of the cutoff time. Among hematologic and biochemical tests, the average time of prothrombin time (PT) and partial thromboplastin time (PTT) was significantly different between the control and test samples (p = 0.001). Our findings on electrified blood with expanding CT, PT, and PTT times revealed that the electric current passing through the blood enhanced the CT. Furthermore, no change in biochemical or hematological factors demonstrated that this current had no detrimental effect on the blood.

© 2022 S. Karger AG, Basel

References Bowen RAR, Hortin GL, Csako G, Otañez OH, Remaley AT. Impact of blood collection devices on clinical chemistry assays. Clin Biochem. 2010;43(1–2):4–25. Sappington SW. The use of heparin in blood transfusions. J Am Med Assoc. 1939;113(1):22–5. Kessler M, Moureau F, Nguyen P. Anticoagulation in chronic hemodialysis: progress toward an optimal approach. Semin Dial. 2015;28(5):474–89. Puis L, Milojevic M, Boer C, De Somer FMJJ, Gudbjartsson T, van den Goor J, et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Interact Cardiovasc Thorac Surg. 2020;30(2):161–202. Minet V, Dogné JM, Mullier F. Functional assays in the diagnosis of heparin-induced thrombocytopenia: a review. Molecules. 2017;22(4):617. Gameiro J, Jorge S, Lopes JA. Haemodialysis-related-heparin-induced thrombocytopenia: case series and literature review. Nefrología. 2018;38(5):551–7. Shen JI, Mitani AA, Chang TI, Winkelmayer WC. Use and safety of heparin-free maintenance hemodialysis in the USA. Nephrol Dial Transplant. 2013;28(6):1589–602. Singer RF, Williams O, Mercado C, Chen B, Talaulikar G, Walters G, et al. Regional citrate anticoagulation in hemodialysis: an observational study of safety, efficacy, and effect on calcium balance during routine care. Can J Kidney Health Dis. 2016;3(1):22–10. Lazrak HH, René É, Elftouh N, Leblanc M, Lafrance JP. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis. BMC Nephrol. 2017;18(1):187–12. Skoog DA, West DM, Holler FJ, Crouch SR. Fundamentals of analytical chemistry. Nelson Education; 2013. Simona BR, Brunisholz RA, Morhard R, Hunziker P, Vörös J. Coagulation at the blood–electrode interface: the role of electrochemical desorption and degradation of fibrinogen. Langmuir. 2014;30(24):7227–34. Tara K, Sarkar AK. Relationship between level of blood sugar and current profile by electrolysis process. International conference on advances in electrical engineering (ICAEE). IEEE; 2017. p. 527–30. Abdalla S, Al-Ameer SS, Al-Magaishi SH. Electrical properties with relaxation through human blood. Biomicrofluidics. 2010;4(3):034101. Abdalla S, Al-Marzouki F, Al-Ghamdi A, Al-Malki AL. Role of erythrocytes and leucocytes in charge transfer through human blood. J Mol Liquids. 2012;173:144–52. McPherson RA. Henry’s clinical diagnosis and management by laboratory methods: first South Asia Edition_e-Book. Elsevier India; 2017. Delangis PA, Yen TF. Electronic antihemocoagulation. Biomater Med Devices Artif Organs. 1986;14(3–4):195–225. Sawyer P, Brattain W, Boddy P. Electrochemical precipitation of human blood cells and its possible relation to intravascular thrombosis. Proc Natl Acad Sci U S A. 1964;51(3):428–32. Sawyer PN. Biophysical mechanisms in vascular homeostasis and intravascular thrombosis. Appleton-Century-Crofts; 1965. Chaudhry R, Babiker HM. Physiology, coagulation pathways [Internet]. StatPearls; 2019. Frąckiewicz J, Włodarek D, Brzozowska A, Wierzbicka E, Słowińska MA, Wądołowska L, et al. Hematological parameters and all-cause mortality: a prospective study of older people. Aging Clin Exp Res. 2018;30(5):517–26. Burns ER, Yoshikawa N. Hemolysis in serum samples drawn by emergency department personnel versus laboratory phlebotomists. Lab Med. 2002;33(5):378–80. Laga AC, Cheves TA, Sweeney JD. The effect of specimen hemolysis on coagulation test results. Am J Clin Pathol. 2006 Nov;126(5):748–55. Liamis G, Liberopoulos E, Barkas F, Elisaf M. Spurious electrolyte disorders: a diagnostic challenge for clinicians. Am J Nephrol. 2013;38(1):50–7. Leite Carlos MM, Melo MM, Soto-Blanco B. Influence of sex on activated partial thromboplastin time (aPTT) and prothrombin time (PT) in sheep. Vet Ital. 2017;53(3):255–8. Winter WE, Flax SD, Harris NS. Coagulation testing in the core laboratory. Lab Med. 2017;48(4):295–313. Varga-Szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thromb Haemost. 2009;7(7):1057–66. Solzbach U, Kitterer HR, Haas H. Reversible congestive heart failure in severe hypocalcemia. Herz. 2010;35(7):507–10. Fiaccadori E, Regolisti G, Cademartiri C, Cabassi A, Picetti E, Barbagallo M, et al. Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment. Clin J Am Soc Nephrol. 2013 Oct;8(10):1670–8. Oudemans-van Straaten HM, Ostermann M. Bench-to-bedside review: citrate for continuous renal replacement therapy, from science to practice. Crit Care. 2012;16(6):249–9. Buturovic-Ponikvar J. Is regional citrate anticoagulation the future of hemodialysis? Ther Apher Dial. 2016;20(3):234–9. Janssen M, Huijgensz P, Bourman A, Oe P, Donker A, Van Der Meulen J. Citrate versus heparin anticoagulation in chronic haernodialysis patients. Nephrol Dial Transplant. 1993;8(11):1228–33. Dyla A, Mielnicki W, Bartczak J, Zawada T, Garba P. Effectiveness and safety assessment of citrate anticoagulation during albumin dialysis in comparison to other methods of anticoagulation. Artif Organs. 2017;41(9):818–26. Fernández SN, Santiago MJ, López-Herce J, García M, Del Castillo J, Alcaraz AJ, et al. Citrate anticoagulation for CRRT in children: comparison with heparin. BioMed Res Int. 2014;2014:786301. Fathima N, Kashif T, Janapala RN, Jayaraj JS, Qaseem A. Single-best choice between intermittent versus continuous renal replacement therapy: a review. Cureus. 2019 Sep 3;11(9):e5558. Article / Publication Details

First-Page Preview

Abstract of Clinical Engineering - Methods Article

Received: November 05, 2021
Accepted: July 15, 2022
Published online: September 20, 2022

Number of Print Pages: 10
Number of Figures: 4
Number of Tables: 2

ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)

For additional information: https://www.karger.com/BPU

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

留言 (0)

沒有登入
gif